JP2025026843A5 - - Google Patents

Info

Publication number
JP2025026843A5
JP2025026843A5 JP2024185014A JP2024185014A JP2025026843A5 JP 2025026843 A5 JP2025026843 A5 JP 2025026843A5 JP 2024185014 A JP2024185014 A JP 2024185014A JP 2024185014 A JP2024185014 A JP 2024185014A JP 2025026843 A5 JP2025026843 A5 JP 2025026843A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
antibody
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024185014A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025026843A (ja
Filing date
Publication date
Priority claimed from JP2022500544A external-priority patent/JP7579589B2/ja
Application filed filed Critical
Publication of JP2025026843A publication Critical patent/JP2025026843A/ja
Publication of JP2025026843A5 publication Critical patent/JP2025026843A5/ja
Pending legal-status Critical Current

Links

JP2024185014A 2019-07-05 2024-10-21 Ranタンパク質関連神経学的疾患を処置するための方法 Pending JP2025026843A (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201962871031P 2019-07-05 2019-07-05
US62/871,031 2019-07-05
US202063025096P 2020-05-14 2020-05-14
US63/025,096 2020-05-14
JP2022500544A JP7579589B2 (ja) 2019-07-05 2020-07-02 Ranタンパク質関連神経学的疾患を処置するための方法
PCT/US2020/040725 WO2021007110A1 (en) 2019-07-05 2020-07-02 Methods for treating ran protein-associated neurological diseases

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2022500544A Division JP7579589B2 (ja) 2019-07-05 2020-07-02 Ranタンパク質関連神経学的疾患を処置するための方法

Publications (2)

Publication Number Publication Date
JP2025026843A JP2025026843A (ja) 2025-02-26
JP2025026843A5 true JP2025026843A5 (https=) 2025-09-29

Family

ID=74114201

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022500544A Active JP7579589B2 (ja) 2019-07-05 2020-07-02 Ranタンパク質関連神経学的疾患を処置するための方法
JP2024185014A Pending JP2025026843A (ja) 2019-07-05 2024-10-21 Ranタンパク質関連神経学的疾患を処置するための方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2022500544A Active JP7579589B2 (ja) 2019-07-05 2020-07-02 Ranタンパク質関連神経学的疾患を処置するための方法

Country Status (6)

Country Link
US (1) US20220267776A1 (https=)
EP (1) EP3994159A4 (https=)
JP (2) JP7579589B2 (https=)
AU (1) AU2020310843A1 (https=)
CA (1) CA3145291A1 (https=)
WO (1) WO2021007110A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10509045B2 (en) 2015-05-29 2019-12-17 University Of Florida Research Foundation, Incorporated Methods for diagnosing Huntington's disease
US10940161B2 (en) 2016-04-04 2021-03-09 University Of Florida Research Foundation, Incorporated Manipulation of EIF3 to modulate repeat associated non-ATG (RAN) translation
WO2018195110A1 (en) 2017-04-17 2018-10-25 University Of Florida Research Foundation, Incorporated Regolation of ran translation by pkr and eif2a-p pathways
AU2018308088B2 (en) 2017-07-25 2025-05-29 Truebinding, Inc. Treating cancer by blocking the interaction of TIM-3 and its ligand
JP2020535448A (ja) 2017-09-25 2020-12-03 ユニバーシティー オブ フロリダ リサーチ ファンデーション, インク. Ranタンパク質の検出のための免役アッセイ
US11903910B2 (en) 2017-09-26 2024-02-20 University Of Florida Research Foundation, Incorporated Use of metformin and analogs thereof to reduce RAN protein levels in the treatment of neurological disorders
AU2020214796A1 (en) 2019-01-30 2021-07-29 Truebinding, Inc. Anti-Gal3 antibodies and uses thereof
WO2021055880A1 (en) 2019-09-20 2021-03-25 University Of Florida Researchfoundation, Incorporated Detection of antibodies against ran proteins from serum and tissue lysates
WO2021242776A2 (en) 2020-05-26 2021-12-02 Truebinding, Inc. Methods of treating inflammatory diseases by blocking galectin-3
WO2023077153A1 (en) * 2021-11-01 2023-05-04 University Of Florida Research Foundation, Incorporated Poly-ga proteins in alzheimer's disease
WO2023102111A1 (en) 2021-12-01 2023-06-08 University Of Florida Research Foundation, Incorporated Small molecule inhibitors of repeat associated non-aug (ran) translation and combination therapies
AU2023373378A1 (en) * 2022-11-01 2025-04-24 University Of Florida Research Foundation, Incorporated Interrupted ran proteins in disease
WO2024173816A1 (en) * 2023-02-17 2024-08-22 The University Of North Carolina At Chapel Hill Methods of detecting telomere-encoded dipeptide repeat proteins and therapeutic applications
CN116693621B (zh) * 2023-03-02 2023-11-14 东北农业大学 抑制革兰氏阴性菌的窄谱抗菌肽pc及其制备方法和应用
WO2025019730A1 (en) * 2023-07-20 2025-01-23 University Of Florida Research Foundation, Incorporated Engineered ga antibodies for therapy development
WO2025128551A1 (en) * 2023-12-11 2025-06-19 University Of Florida Research Foundation, Incorporated Aav-based anti-ga therapy

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2948777T (pt) * 2013-01-22 2019-09-26 Deutsches Zentrum Fuer Neurodegenerative Erkrankungen E V Proteínas de repetição por dipeptídeos como alvo terapêutico em doenças neurodegenerativas com expansão de hexanucleotídico repetido
WO2014159247A1 (en) * 2013-03-14 2014-10-02 University Of Florida Research Foundation, Inc. Di-amino acid repeat-containing proteins associated with als
EP3177322A4 (en) * 2014-08-08 2018-07-18 Alector LLC Anti-trem2 antibodies and methods of use thereof
JP6432023B2 (ja) * 2014-12-02 2018-12-05 国立大学法人 東京医科歯科大学 脊髄小脳失調症31型(sca31)治療剤
US10509045B2 (en) * 2015-05-29 2019-12-17 University Of Florida Research Foundation, Incorporated Methods for diagnosing Huntington's disease
US10940161B2 (en) * 2016-04-04 2021-03-09 University Of Florida Research Foundation, Incorporated Manipulation of EIF3 to modulate repeat associated non-ATG (RAN) translation
TW201920672A (zh) * 2017-08-08 2019-06-01 新加坡商波濤生命科學有限公司 寡核苷酸組合物及其使用方法
JP2020535448A (ja) * 2017-09-25 2020-12-03 ユニバーシティー オブ フロリダ リサーチ ファンデーション, インク. Ranタンパク質の検出のための免役アッセイ
US11903910B2 (en) * 2017-09-26 2024-02-20 University Of Florida Research Foundation, Incorporated Use of metformin and analogs thereof to reduce RAN protein levels in the treatment of neurological disorders

Similar Documents

Publication Publication Date Title
JP2025026843A5 (https=)
TWI789644B (zh) 抗-N3pGlu類澱粉β肽抗體及其用途
TWI374893B (en) Humanized antibodies that recognize beta amyloid peptide
CN105849124B (zh) 双重特异性抗体
ES2664128T3 (es) Anticuerpos anti péptido Beta Amiloide N3pGlu y usos de los mismos
JP2021524267A5 (https=)
TW201525004A (zh) 結合前蛋白轉化酶枯草桿菌蛋白酶加工酶9型之人類抗原結合蛋白
JP2018021041A (ja) Rgm aタンパク質に対するモノクローナル抗体及びその使用
CA2478049A1 (en) Humanized antibodies that recognize beta amyloid peptide
KR20150080033A (ko) 골관절염 및 통증의 치료 방법
JP2003523764A5 (https=)
JP2021101720A5 (https=)
JP2016007218A (ja) 改善された抗tnfr1ポリペプチド、抗体可変ドメインおよびアンタゴニスト
JP2007097598A5 (https=)
JP2009535021A5 (https=)
US20220372127A1 (en) Aqueous pharmaceutical composition of an anti-il17a antibody and use thereof
US10723787B2 (en) Methods for alleviating symptoms of sporadic amyotrophic lateral sclerosis by neutralizing a HERV-K envelope protein using an anti-HERV-K envelope protein antibody
JPWO2020011966A5 (https=)
EP2673635A2 (en) Apoe immunotherapy
US20250171557A1 (en) Therapeutic agent for neurodegenerative disorder
WO2016201434A2 (en) Stable formulations of humanized anti-tau antibody
JP2020527152A5 (https=)
JP2023535024A (ja) 抗aベータ抗体
JPWO2021007110A5 (https=)
JPWO2018206790A5 (https=)